Selective induction of tumor ischemia: development of vascular targeting agents for cancer therapy.
Chaplin
David J
DJ
OXiGENE Inc, 321 Arsenal Street, Watertown, MA 02472, USA. dchaplin@oxigene.com
Hill
Sally A
SA
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D007511:Ischemia / Q000139:chemically induced*; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000503:physiopathology; D013678:Technology, Pharmaceutical / Q000379:methods
D000970:Antineoplastic Agents